Has Mara Young received payments from drug or device companies?

Yes. Drug and device makers reported $3,457 in general payments to Mara Young across 121 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mara Young did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mara Young come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mara Young

Family · University Place, WANPI 1770359218

Payments from drug & device makers

$3,457in general payments, 2019–2025

Across 121 payments — averaging $28.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$689
Corcept Therapeutics$523
Novo Nordisk$427
Lilly USA, LLC$349
Phathom Pharmaceuticals, Inc.$264
Boehringer Ingelheim$238
plus $967 from 15 others

What the payments were for

Food & beverage$3,457100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	39	$689
Corcept Therapeutics	10	$523
Novo Nordisk	11	$427
Lilly USA, LLC	8	$349
Phathom Pharmaceuticals, Inc.	7	$264
Boehringer Ingelheim	7	$238
Otsuka America Pharmaceutical, Inc.	9	$168
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$143
Alkermes, Inc.	5	$106
Lundbeck LLC	3	$93
Exact Sciences	4	$76
Dexcom, Inc.	2	$63
Takeda Pharmaceuticals U.S.A., Inc.	2	$57
Johnson & Johnson	2	$52
GSK	2	$50
Bayer	2	$36
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$35
Xeris Pharmaceuticals, Inc.	1	$23
Abbott	1	$22
Pfizer	1	$22
Phadia US Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,457 in reported general payments places this provider in the 90th percentile of 1,706 family providers in Washington.

See all family providers in Washington →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RybelsusSemaglutide	11	$10,233
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	45	$1,471
Albuterol Sulfate HfaAlbuterol Sulfate	15	$735
Atorvastatin Calcium	19	$504
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	17	$402
Rosuvastatin Calcium	24	$389
Gabapentin	33	$367
Pravastatin Sodium	17	$272
Levothyroxine Sodium	45	$248
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide	16	$207
Cyclobenzaprine Hcl	14	$202
Metoprolol Succinate	21	$188
Losartan Potassium	35	$188
Simvastatin	14	$158
Amlodipine Besylate	42	$130

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskRybelsus	$427	$10,23311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,706 family providers in Washington.

Other family in University Place

Patric SchineCentralia$842K
Sharla PetersonKenmore$192K
Zelda SwainSpokane$83K
Savannah MorganRenton$76K
Kevan PettersonSeattle$56K
Kelly McFeeSunnyside$42K
Cheryl SomersSpokane$31K
Hye-Jin GehringBellevue$30K
Kaitlin BrasierSeattle$29K
Karen JohnsonSeattle$16K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →